HEADER TRANSFERASE 12-MAR-18 6FYO TITLE X-RAY STRUCTURE OF CLK1-KD(148-484)/CPD-2 AT 2.32A COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CDC-LIKE KINASE 1; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK1, CLK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SPLICING, TRANSFERASE, KINASE, TYROSINE-PROTEIN KINASE, SERINE/ KEYWDS 2 THREONINE- PROTEIN KINASE, NUCLEOTIDE-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 5 17-JAN-24 6FYO 1 REMARK REVDAT 4 03-OCT-18 6FYO 1 REMARK REVDAT 3 26-SEP-18 6FYO 1 JRNL REVDAT 2 12-SEP-18 6FYO 1 JRNL REVDAT 1 18-JUL-18 6FYO 0 JRNL AUTH J.KALLEN,C.BERGSDORF,B.ARNAUD,M.BERNHARD,M.BRICHET, JRNL AUTH 2 A.COBOS-CORREA,A.ELHAJOUJI,F.FREULER,I.GALIMBERTI, JRNL AUTH 3 C.GUIBOURDENCHE,S.HAENNI,S.HOLZINGER,J.HUNZIKER,A.IZAAC, JRNL AUTH 4 M.KAUFMANN,L.LEDER,H.J.MARTUS,P.VON MATT,V.POLYAKOV, JRNL AUTH 5 P.ROETHLISBERGER,G.ROMA,N.STIEFL,M.UTENG,A.LERCHNER JRNL TITL X-RAY STRUCTURES AND FEASIBILITY ASSESSMENT OF CLK2 JRNL TITL 2 INHIBITORS FOR PHELAN-MCDERMID SYNDROME. JRNL REF CHEMMEDCHEM V. 13 1997 2018 JRNL REFN ESSN 1860-7187 JRNL PMID 29985556 JRNL DOI 10.1002/CMDC.201800344 REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 14502 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 764 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2727 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.13000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : -0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.499 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.249 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.161 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.606 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6FYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009141. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99998 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15267 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 19.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.33400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5J1W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350,0.2M AMMONIUM SULFATE, REMARK 280 0.1M TRIS, PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.75550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 146 REMARK 465 PRO A 147 REMARK 465 PRO A 307 REMARK 465 LYS A 308 REMARK 465 ILE A 309 REMARK 465 LYS A 482 REMARK 465 SER A 483 REMARK 465 ILE A 484 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 160 -36.08 -153.89 REMARK 500 ASN A 195 24.28 -78.92 REMARK 500 THR A 287 -21.51 69.27 REMARK 500 ASP A 325 79.82 57.70 REMARK 500 SER A 341 158.52 76.62 REMARK 500 SER A 357 -144.23 -151.41 REMARK 500 PHE A 379 67.84 -117.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAQ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FYI RELATED DB: PDB REMARK 900 RELATED ID: 6FYK RELATED DB: PDB REMARK 900 RELATED ID: 6FYL RELATED DB: PDB DBREF 6FYO A 148 484 UNP P49759 CLK1_HUMAN 148 484 SEQADV 6FYO GLY A 146 UNP P49759 EXPRESSION TAG SEQADV 6FYO PRO A 147 UNP P49759 EXPRESSION TAG SEQRES 1 A 339 GLY PRO HIS LEU ILE CYS GLN SER GLY ASP VAL LEU SER SEQRES 2 A 339 ALA ARG TYR GLU ILE VAL ASP THR LEU GLY GLU GLY ALA SEQRES 3 A 339 PHE GLY LYS VAL VAL GLU CYS ILE ASP HIS LYS ALA GLY SEQRES 4 A 339 GLY ARG HIS VAL ALA VAL LYS ILE VAL LYS ASN VAL ASP SEQRES 5 A 339 ARG TYR CYS GLU ALA ALA ARG SER GLU ILE GLN VAL LEU SEQRES 6 A 339 GLU HIS LEU ASN THR THR ASP PRO ASN SER THR PHE ARG SEQRES 7 A 339 CYS VAL GLN MET LEU GLU TRP PHE GLU HIS HIS GLY HIS SEQRES 8 A 339 ILE CYS ILE VAL PHE GLU LEU LEU GLY LEU SER THR TYR SEQRES 9 A 339 ASP PHE ILE LYS GLU ASN GLY PHE LEU PRO PHE ARG LEU SEQRES 10 A 339 ASP HIS ILE ARG LYS MET ALA TYR GLN ILE CYS LYS SER SEQRES 11 A 339 VAL ASN PHE LEU HIS SER ASN LYS LEU THR HIS THR ASP SEQRES 12 A 339 LEU LYS PRO GLU ASN ILE LEU PHE VAL GLN SER ASP TYR SEQRES 13 A 339 THR GLU ALA TYR ASN PRO LYS ILE LYS ARG ASP GLU ARG SEQRES 14 A 339 THR LEU ILE ASN PRO ASP ILE LYS VAL VAL ASP PHE GLY SEQRES 15 A 339 SER ALA THR TYR ASP ASP GLU HIS HIS SER THR LEU VAL SEQRES 16 A 339 SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU ALA SEQRES 17 A 339 LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE GLY SEQRES 18 A 339 CYS ILE LEU ILE GLU TYR TYR LEU GLY PHE THR VAL PHE SEQRES 19 A 339 PRO THR HIS ASP SER LYS GLU HIS LEU ALA MET MET GLU SEQRES 20 A 339 ARG ILE LEU GLY PRO LEU PRO LYS HIS MET ILE GLN LYS SEQRES 21 A 339 THR ARG LYS ARG LYS TYR PHE HIS HIS ASP ARG LEU ASP SEQRES 22 A 339 TRP ASP GLU HIS SER SER ALA GLY ARG TYR VAL SER ARG SEQRES 23 A 339 ARG CYS LYS PRO LEU LYS GLU PHE MET LEU SER GLN ASP SEQRES 24 A 339 VAL GLU HIS GLU ARG LEU PHE ASP LEU ILE GLN LYS MET SEQRES 25 A 339 LEU GLU TYR ASP PRO ALA LYS ARG ILE THR LEU ARG GLU SEQRES 26 A 339 ALA LEU LYS HIS PRO PHE PHE ASP LEU LEU LYS LYS SER SEQRES 27 A 339 ILE HET EAQ A 501 27 HET SO4 A 502 5 HET SO4 A 503 5 HET SO4 A 504 5 HETNAM EAQ 6-~{TERT}-BUTYL-~{N}-[6-(1~{H}-PYRAZOL-4-YL)-1~{H}- HETNAM 2 EAQ IMIDAZO[1,2-A]PYRIDIN-2-YL]PYRIDINE-3-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 2 EAQ C20 H21 N6 O FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 HOH *144(H2 O) HELIX 1 AA1 LYS A 182 GLY A 184 5 3 HELIX 2 AA2 VAL A 196 ASP A 217 1 22 HELIX 3 AA3 SER A 247 ASN A 255 1 9 HELIX 4 AA4 ARG A 261 ASN A 282 1 22 HELIX 5 AA5 LYS A 290 GLU A 292 5 3 HELIX 6 AA6 THR A 342 ARG A 346 5 5 HELIX 7 AA7 ALA A 347 LEU A 352 1 6 HELIX 8 AA8 GLN A 358 GLY A 375 1 18 HELIX 9 AA9 ASP A 383 GLY A 396 1 14 HELIX 10 AB1 PRO A 399 THR A 406 1 8 HELIX 11 AB2 LYS A 408 LYS A 410 5 3 HELIX 12 AB3 SER A 423 CYS A 433 1 11 HELIX 13 AB4 PRO A 435 MET A 440 5 6 HELIX 14 AB5 ASP A 444 LEU A 458 1 15 HELIX 15 AB6 THR A 467 LEU A 472 1 6 HELIX 16 AB7 LYS A 473 LYS A 481 5 9 SHEET 1 AA1 6 VAL A 156 LEU A 157 0 SHEET 2 AA1 6 TYR A 161 GLY A 170 -1 O TYR A 161 N LEU A 157 SHEET 3 AA1 6 GLY A 173 ASP A 180 -1 O ILE A 179 N GLU A 162 SHEET 4 AA1 6 HIS A 187 VAL A 193 -1 O ILE A 192 N LYS A 174 SHEET 5 AA1 6 HIS A 236 GLU A 242 -1 O PHE A 241 N ALA A 189 SHEET 6 AA1 6 MET A 227 HIS A 233 -1 N GLU A 229 O VAL A 240 SHEET 1 AA2 2 LEU A 284 THR A 285 0 SHEET 2 AA2 2 THR A 330 TYR A 331 -1 O THR A 330 N THR A 285 SHEET 1 AA3 2 ILE A 294 PHE A 296 0 SHEET 2 AA3 2 ILE A 321 VAL A 323 -1 O LYS A 322 N LEU A 295 SHEET 1 AA4 2 TYR A 301 TYR A 305 0 SHEET 2 AA4 2 ASP A 312 LEU A 316 -1 O GLU A 313 N ALA A 304 SHEET 1 AA5 2 PHE A 412 HIS A 413 0 SHEET 2 AA5 2 ARG A 416 LEU A 417 -1 O ARG A 416 N HIS A 413 SITE 1 AC1 11 LEU A 167 ALA A 189 LYS A 191 GLU A 206 SITE 2 AC1 11 PHE A 241 GLU A 242 LEU A 244 GLY A 245 SITE 3 AC1 11 LEU A 246 LEU A 295 ASP A 325 SITE 1 AC2 8 ARG A 223 LYS A 267 GLN A 271 LYS A 274 SITE 2 AC2 8 SER A 423 SER A 424 HOH A 617 HOH A 637 SITE 1 AC3 4 LYS A 267 SER A 424 ARG A 427 HOH A 611 SITE 1 AC4 4 ARG A 343 HIS A 382 HOH A 604 HOH A 634 CRYST1 62.039 49.511 65.514 90.00 117.55 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016119 0.000000 0.008409 0.00000 SCALE2 0.000000 0.020198 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017216 0.00000